0001127602-15-011504.txt : 20150316
0001127602-15-011504.hdr.sgml : 20150316
20150316203912
ACCESSION NUMBER: 0001127602-15-011504
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150313
FILED AS OF DATE: 20150316
DATE AS OF CHANGE: 20150316
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOGEN IDEC INC.
CENTRAL INDEX KEY: 0000875045
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330112644
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 7814642000
MAIL ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC
DATE OF NAME CHANGE: 20031112
FORMER COMPANY:
FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE
DATE OF NAME CHANGE: 19970530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCANGOS GEORGE A
CENTRAL INDEX KEY: 0001202102
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19311
FILM NUMBER: 15704659
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94083
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-03-13
0000875045
BIOGEN IDEC INC.
BIIB
0001202102
SCANGOS GEORGE A
BIOGEN IDEC INC.
225 BINNEY STREET
CAMBRIDGE
MA
02142
1
1
Chief Executive Officer
Common Stock
2015-03-13
4
S
0
537
412.688
D
45176
D
Common Stock
5378
I
by Trust
Common Stock
5378
I
by Trust
Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
This represents the weighted average price for shares sold at a range between $412.63 (low) and $412.76 (high).
/s/ Matthew S. Gilman, Attorney in Fact for George A. Scangos
2015-03-16